An Open Label, Pilot Study Evaluating the Efficacy and Safety of the Use of Nasal Carbon Dioxide for the Treatment of Episodic Cluster Headache

Trial Profile

An Open Label, Pilot Study Evaluating the Efficacy and Safety of the Use of Nasal Carbon Dioxide for the Treatment of Episodic Cluster Headache

Discontinued
Phase of Trial: Phase II

Latest Information Update: 11 May 2017

At a glance

  • Drugs Carbon dioxide (Primary)
  • Indications Cluster headache
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Apr 2017 Status changed from recruiting to discontinued.
    • 09 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 03 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top